Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply

被引：0
|
作者：
Giada Crescioli
Cecilia Lanzi
Guido Mannaioni
Alfredo Vannacci
Niccolò Lombardi
机构：
[1] University of Florence,Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology
[2] Tuscan Regional Centre of Pharmacovigilance,Toxicology Unit and Poison Centre
[3] Careggi University Hospital,undefined
来源：
Internal and Emergency Medicine | 2021年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：799 / 800
页数：1
相关论文
共 50 条
  • [1] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions-reply
    Crescioli, Giada
    Lanzi, Cecilia
    Mannaioni, Guido
    Vannacci, Alfredo
    Lombardi, Niccolo
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 799 - 800
  • [2] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions
    Giada Crescioli
    Valentina Brilli
    Cecilia Lanzi
    Andrea Burgalassi
    Alessandra Ieri
    Roberto Bonaiuti
    Elias Romano
    Rinaldo Innocenti
    Guido Mannaioni
    Alfredo Vannacci
    Niccolò Lombardi
    Internal and Emergency Medicine, 2021, 16 : 697 - 710
  • [3] Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions
    Crescioli, Giada
    Brilli, Valentina
    Lanzi, Cecilia
    Burgalassi, Andrea
    Ieri, Alessandra
    Bonaiuti, Roberto
    Romano, Elias
    Innocenti, Rinaldo
    Mannaioni, Guido
    Vannacci, Alfredo
    Lombardi, Niccolo
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 697 - 710
  • [4] Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
    Alfredo Jose Pardo-Cabello
    Victoria Manzano-Gamero
    Susana Belda-Rustarazo
    Pilar Giner-Escobar
    Internal and Emergency Medicine, 2021, 16 : 797 - 798
  • [5] Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug-drug interactions-comment
    Pardo-Cabello, Alfredo Jose
    Manzano-Gamero, Victoria
    Belda-Rustarazo, Susana
    Giner-Escobar, Pilar
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (03) : 797 - 798
  • [6] Cutaneous adverse drug reactions in hospitalised patients
    Lee, H. Y.
    Tay, L. K.
    Thirumoorthy, T.
    Pang, S. M.
    SINGAPORE MEDICAL JOURNAL, 2010, 51 (10) : 767 - 774
  • [7] Drug-Drug Interactions - Induced Adverse Drug Reactions in Hospitalized Patients
    Ponte, M.
    Serra, H.
    Wachs, A.
    DRUG SAFETY, 2012, 35 (10) : 882 - 882
  • [8] Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions
    Verbic, Matej Dobravc
    Brvar, Miran
    Kos, Mojca Kerec
    ACTA PHARMACEUTICA, 2023, 73 (02) : 195 - 210
  • [9] Adverse Cutaneous Drug Reactions - Case Series
    Sukanya, M.
    Srinivasan, Shreya
    Sanjay, Nehete Sanket
    Kumar, Ashok N.
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (05): : 32 - 35
  • [10] Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2
    Yalcin, Nadir
    Demirkan, Kutay
    ARCHIVES OF DISEASE IN CHILDHOOD, 2023, 108 (10)
12345